Cardiovascular autonomic neuropathy: The clinical significance of its determination

Endocrinologist

Volumn 10, Issue 1, 2000, Pages 27-33

  Maser, Raelene E ^a,b,c   Lenhard, M James ^b   DeCherney, G Stephen ^b  

^a UNIVERSITY OF DELAWARE   (United States)

^b CHRISTIANA CARE HEALTH SYSTEM   (United States)

^c CHRISTIANA HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; QUINAPRIL; THIOCTIC ACID;

AUTONOMIC DYSFUNCTION; AUTONOMIC NEUROPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR REFLEX; DIABETES MELLITUS; ELECTROCARDIOGRAM; EXERCISE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART RATE VARIABILITY; HUMAN; KINESIOTHERAPY; MORTALITY; ORTHOSTATIC HYPOTENSION; REVIEW; RISK FACTOR; SINUS ARRHYTHMIA; VALSALVA MANEUVER;

EID: 0033980538     PISSN: 10512144     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019616-200010010-00006     Document Type: Review

References (55)

1. Schumer MP, Joyner SA, Pfeifer MA: Cardiovascular autonomic neuropathy testing in patients with diabetes. Diabetes Spectrum 1998; 11: 227-31.
2. Ziegler D, Gries FA, Spuler M, Lessmann F, Diabetic Cardiovascular Autonomic Neuropathy Multicenter Study Group: The epidemiology of diabetic neuropathy. J Diabetes Complications 1992; 6: 49-57.
3. Ziegler D, Dannehl K, Volksw D, Muhlen H, Spuler M, Gries FA: Prevalence of cardiovascular autonomic dysfunction assessed by spectral analysis and standard tests of heart-rate variation in newly diagnosed IDDM patients. Diabetes 1992; 15: 908-11.
4. Kennedy WR, Navarro X, Sutherland DER: Neuropathy profile of diabetic patients in a pancreas transplantation program. Neurology 1995; 45: 773-80.
5. American Diabetes Association: Autonomic nervous system testing (Consensus Statement). Diabetes Care 1992; 15(Suppl. 3): 1095-103.
6. Pfeifer MA, Cook D, Brodsky J, et al.: Quantitative evaluation of cardiac parasympathetic activity in normal and diabetic man. Diabetes 1982; 31: 339-45.
7. Genovely H, Pfeifer MA: RR-variation: the autonomic test of choice in diabetes. Diabetes/Metab Rev 1988; 4: 255-71.
8. Vinik AI, Holland MT, Le BeauJM, Liuzzi FJ, Stansberry KB, Colen LB: Diabetic neuropathies. Diabetes Care 1992; 15: 1926-75.
9. Pfeifer MA: Cardiovascular autonomic neuropathy: advances in testing help unlock its complexity. Diabetes Spectrum 1990; 3: 45-8.
10. Vanninen E, Uusitupa M, Lansimies E, Siitonen O, Laitinen J: Effect of metabolic control on autonomic function in obese patients with newly diagnosed type 2 diabetes. Diabetic Med 1993; 10: 66-73.
11. Purewal TS, Watkins PJ: Postural hypotension in diabetic autonomic neuropathy: a review. Diabetic Med 1995; 12: 192-200.
12. Spallone V, Menzinger G: Diagnosis of cardiovascular autonomic neuropathy in diabetes. Diabetes 1997; 46(Suppl. 2): S67-76.
13. Liao D, Barnes RW, Chambless LE, Simpson RJ, Sorlie P, Heiss G for the ARIC investigators: Age, race, and sex differences in autonomic cardiac function measured by spectral analysis of heart rate variability - The ARIC Study. Am J Cardiol 1995; 76: 906-12.
14. Turpeinen AK, Vanninen E, Kuikka JT, Uusitupa MIJ: Demonstration of regional sympathetic denervation of the heart in diabetes. Comparison between patients with NIDDM and IDDM. Diabetes Care 1996; 19: 1083-90.
15. 123I-MIBG myocardial scintigraphy and • power spectral analysis of heart rate variability. Diabetic Med 1996; 13: 266-72.
16. Cosson E, Mayaudon H, Ducorps M, et al.: Value of scintigraphy using meta-iodo-benzyl-guanidine (MIBG) in the investigation of cardiac autonomic neuropathy in diabetic patients. Comparison with Ewing tests. Arch Mal Coeur Vaiss 1997; 90: 1055-8.
17. Kahn JK, Zola B, Juni JE, Vinik AI: Decreased exercise heart rate and blood pressure response in diabetic subjects with cardiac autonomie neuropathy. Diabetes Care 1986; 9: 389-94.
18. Roy TM, Peterson HR, Snider HL, et al.: Autonomic influence on cardiovascular performance in diabetic subjects. Am J Med 1989; 87: 382-8.
19. Albright AL: Exercise precautions and recommendations for patients with autonomic neuropathy. Diabetes Spectrum 1998; 11: 231-7.
20. Burgos LG, Ebert TJ, Asiddao C, et al.: Increased intraoperative cardiovascular morbidity in diabetics with autonomic neuropathy. Anesthesiology 1989; 70: 591-7.
21. Knuttgen D, Weidemann D, Doehn M: Diabetic autonomic neuropathy: abnormal cardiovascular reactions under general anesthesia. Klin Wochenschr 1990; 68: 1168-72.
22. Latson TW, Ashmore TH, Reinhart DJ, Klein KW, Giesecke AH: Autonomic reflex dysfunction in patients presenting for elective surgery is associated with hypotension after anesthesia induction. Anesthesiology 1994; 80: 326-37.
23. Keyl C, Lemberger P, Palitzsch KD, Hochmuth K, Liebold A, Hobbhahn J: Cardiovascular autonomic dysfunction and hemodynamic response to anesthetic induction in patients with coronary artery disease and diabetes mellitus. Anesth Analg 1999; 88: 985-91.
24. Gilden JL: Orthostatic hypotension in individuals with diabetes. Diabetes Spectrum 1998; 11: 237-41.
25. Bloomgarden ZT: International Diabetes Federation Meeting, 1997: neuropathy, information technology, cost of diabetes care, and epidemiology. Diabetes Care 1998; 21: 1198-202.
26. Harati Y: Diabetic peripheral neuropathy. In Medical and Surgical Management of the Diabetic Foot, edited by Kominsky SJ, p. 83, St. Louis, Mosby 1994.
27. Koistinen MJ: Prevalence of asymptomatic myocardial ischemia in diabetic subjects. Br Med J 1990; 301: 92-5.
28. Marchant B, Umachandran V, Stevenson R, Kopelman PO, Timmis AD: Silent myocardial ischemia: role of subclinical neuropathy in patients with and without diabetes. J Am Coll Cardiol 1993; 22: 1433-7.
29. Langer A, Freeman MR, Josse RG, Steiner G, Armstrong PW: Detection of silent myocardial ischemia in diabetes mellitus. Am J Cardiol 1991; 67: 1073-8.
30. O'Sullivan JJ, Conroy RM, MacDonald K, McKenna TJ, Maurer BJ: Silent ischemia in diabetic men with autonomic neuropathy. Br Heart J 1991; 66: 313-5.
31. Koistinen MJ, Airaksinen KEJ, Huikuri HV, et al.: No difference in cardiac innervation of diabetic patients with painful and asymptomatic coronary artery disease. Diabetes Care 1996; 19: 231-5.
32. Ewing DJ, Campbell IW, Clarke BF: The natural history of diabetic autonomic neuropathy. Q J Med 1980; 49: 95-108.
33. Navarro X, Kennedy WR, Loewenson RB, Sutherland DER: Influence of pancreas transplantation on cardiorespiratory reflexes, nerve conduction, and mortality in diabetes mellitus. Diabetes 1990; 39: 802-6.
34. Sampson MJ, Wilson S, Karagiannis P, Edmonds M, Watkins PJ: Progression of diabetic autonomic neuropathy over a decade in insulin-dependent diabetics. Q J Med 1990; 75: 635-46.
35. Jermendy G: QT interval in diabetic patients with cardiac autonomic neuropathy. Diabetes Care 1995; 18: 275-6.
36. Orchard TJ, Lloyd CE, Maser RE, Kuller LH: Why does diabetic autonomic neuropathy predict IDDM mortality? An analysis from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Res Cl Pr 1996; 34(Suppl.): S165-71.
37. Maser RE, Pfeifer MA, Dorman JS, Kuller LH, Becker DJ, Orchard TJ: Diabetic autonomic neuropathy and cardiovascular risk. Pittsburgh Epidemiology of Diabetes Complications Study III. Arch Intern Med 1990; 150: 1218-22.
38. Spallone V, Maiello MR, Cicconetti E, Menzinger G: Autonomic neuropathy and cardiovascular risk factors in insulin-dependent and non insulin-dependent diabetes. Diabetes Res Clin Pract 1997; 34: 169-79.
39. Rathmann W, Ziegler D, Jahnke M, Haastert B, Cries FA: Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diabetic Med 1993; 10: 820-4.
40. Spallone V, Bernardi L, Ricordi L, et al.: Relationship between the circadian rhythms of blood pressure and sympathovagal balance in diabetic autonomic neuropathy. Diabetes 1993; 42: 1745-52.
41. Gambardella S, Frontoni S, Spallone V, et al.: Increased left ventricular mass in normotensive diabetic patients with autonomic neuropathy. Am J Hypertens 1993; 6: 97-102.
42. Menzinger G, Gambardella S, Spallone V: The relationship of autonomic neuropathy to other diabetic complications. Diabetic Med 1993; 10(Suppl 2): 74S-76S.
43. Cohen JA, Jeffers BW, Faldut D, Marcoux M, Schrier RW: Risks for sensorimotor peripheral neuropathy and autonomic neuropathy in non-insulin-dependent diabetes mellitus (NIDDM). Muscle Nerve 1998; 21: 72-80.
44. Valensi P, Huard JP, Giroux C, Attali JR: Factors involved in cardiac autonomic neuropathy in diabetic patients. J Diabetes Complications 1997; 11: 180-7.
45. Lauritzen T, Frost-Larsen K, Larsen HW, Deckett T, and the Steno Study Group: Two-year experience with continuous subcutaneous insulin infusion in relation to retinopathy and neuropathy. Diabetes 1985; 34(Suppl. 3): 74-9.
46. Jakobsen J, Christiansen JS, Kristoffersen I, et al.: Autonomic and somatosensory nerve function after 2 years of continuous subcutaneous insulin infusion in type 1 diabetes. Diabetes 1988; 37: 452-5.
47. Mustonen J, Uusitupa M, Mantysaari M, Lansimies E, Pyorala K, Laakso M: Changes in autonomic nervous function during the 4-year follow-up in middle-aged diabetic and nondiabetic subjects initially free of coronary heart disease. J Intern Med 1997; 241: 227-35.
48. The Diabetes Control and Complications Trial Research Group: The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT). Diabetologia 1998; 41: 416-23.
49. Pfeifer MA, Schumer MP, Gelber DA: Aldose reductase inhibitors: the end of an era or the need for different trial designs? Diabetes 1997; 46(Suppl. 2): S82-9.
50. Ziegler D, Schatz H, Conrad F, et al.: Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study): Diabetes Care 1997; 20: 369-73.
51. Kontopoulos AG, Athyros VG, Didangelos TP, et al.: Effect of chronic quinapril administration on heart rate variability in patients with diabetic autonomic neuropathy. Diabetes Care 1997; 20:355-61.
52. Malik RA, Williamson S, Abbott C, et al.: Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial. Lancet 1998; 352: 1978-51.
53. Malfatto G, Facchini M, Bragato R, Branzi G, Sala L, Leonetti G: Short and long term effects of exercise training on the tonic autonomic modulation of heart rate variability after myocardial infarction. Eur Heart J 1996; 17: 532-8.
54. Howorka K, Pumprla J, Haber P, Koller-Strametz J, Mondrzyk J, Schabmann A: Effects of physical training on heart rate variability in diabetic patients with various degrees of cardiovascular autonomic neuropathy. Cardiovasc Res 1997; 34: 206-14.
55. Pfeifer MA, Schumer MP: Cardiovascular autonomic neuropathy: where have we been and where are we going? Diabetes Care 1994; 17: 1545-6.